Anocca gains European authorisation for Phase I/II trial of pancreatic cancer drug
The trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.
Anocca Announces Authorisation of Clinical Trial Application to Start First In-Human Trial in Advanced Pancreatic Cancer
CTA approval marks Anocca’s transition to a clinical-stage companyFirst-in-human VIDAR-1 trial begins with the deployment of ...